Approval · Notice of Compliance 709 · 2002
EVRA: Notice of Compliance 709
Issued August 20, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 709
- Date
- August 20, 2002
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Hormonal contraceptive
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EVRA | 02246340 | Cancelled Post Market |
Medicinal ingredients
- ETHINYL ESTRADIOL 0.75 MG per UNIT
- NORELGESTROMIN 6 MG per UNIT